A Trial Investigating the Efficacy and Safety of NVG-291 in Subjects with Chronic Spinal Cord Injury – A Randomized, Double-Blind, Placebo-Controlled MulticEnter Phase 3 Trial (RESTORE)
Daily subcutaneous injections of NVG-1 to treat of chronic tetraplegia.